Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Clay Thorp currently holds 45,000 shares of Clearside Biomedical, Inc. (CLSD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Clay Thorp has been a net buyer of CLSD stock. They have purchased $10.9M and sold $7.9M worth of shares.
Clay Thorp's most recent insider trade was on Jun 20, 2024, when they sold 45,000 shares at $0.00 per share.
Clay Thorp serves as Executive at Clearside Biomedical, Inc. (CLSD). They have executed 81 insider transactions totaling $18.9M over their tenure at the company.
Clay Thorp holds the position of Executive at Clearside Biomedical, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Clay Thorp has shown a buying trading pattern, with $10.9M in total purchases and $7.9M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Clay Thorp was on Jan 11, 2022, when they purchased $3.7M worth of VIGL shares. This transaction involved 265,000 shares at $14.00 per share.
Clay Thorp currently owns 45,000 shares of Clearside Biomedical, Inc. (CLSD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Clay Thorp's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Clay Thorp has 81 Form 4 filings on record as an insider at Clearside Biomedical, Inc..
Set alerts for Clay Thorp and 40,000+ other insiders.